EDGAR Filing Documents for 0001104659-22-121003

Form 8-K - Current report:

SEC Accession No. 0001104659-22-121003

Filing Date

2022-11-22

Accepted

2022-11-22 08:00:36

Documents

Period of Report

2022-11-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2231091d1_8k.htm iXBRL	8-K	40379
2	EXHIBIT 4.1	tm2231091d1_ex4-1.htm	EX-4.1	99818
3	EXHIBIT 4.2	tm2231091d1_ex4-2.htm	EX-4.2	101985
4	EXHIBIT 4.3	tm2231091d1_ex4-3.htm	EX-4.3	10439
5	EXHIBIT 10.1	tm2231091d1_ex10-1.htm	EX-10.1	238586
6	EXHIBIT 10.2	tm2231091d1_ex10-2.htm	EX-10.2	147461
7	EXHIBIT 99.1	tm2231091d1_ex99-1.htm	EX-99.1	10794
	Complete submission text file	0001104659-22-121003.txt		973390

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	fwbi-20221120.xsd	EX-101.SCH	3045
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	fwbi-20221120_lab.xml	EX-101.LAB	34476
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	fwbi-20221120_pre.xml	EX-101.PRE	22603
12	EXTRACTED XBRL INSTANCE DOCUMENT	tm2231091d1_8k_htm.xml	XML	3608

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)